Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 219-223

  Wang, Jin ^a,b   Yang, Yong Hong ^b   Wang, An Qun ^b   Yao, Bing ^b   Xie, Gang ^b   Feng, Gang ^b   Zhang, Yu ^b   Cheng, Zong Shu ^b   Hui, Li ^b   Dai, Tang Zhi ^b   Du, Xiao Bo ^b   Wang, Dong ^a,b  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b MIANYANG CENTRAL HOSPITAL   (China)

Author keywords

Gastric cancer tissue; Immunohistochemical; Nonneoplastic gastric tissue; Raf kinase inhibitor protein

Indexed keywords

PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS;

GASTRIC MUCOSA; GASTROENTERITIS; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956914539     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9194-z     Document Type: Article

References (19)

1. Bernier I, Jolles P. Purification and characterization of a basic 23 kD acytosolic protein from bovine brain. Biochim Biophys Acta. 1984;790:174-81.
2. Fu Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95(12):878-89.
3. Simister PC, Banfield MJ, Brady RL. The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 6/Pt 2):1077-80.
4. Trakul N, Rosner MR. Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 2005;15:19-23. doi:10.1038/sj.cr. 7290258. (Pubitemid 41653959)
5. Trakul N, et al. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005;280:24931-40. doi:10.1074/jbc. M413929200. (Pubitemid 40934585)
6. Yeung K, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 2002;401:173-7.
7. Yeung KC, et al. Raf kinase inhibitor protein interacts with NFkappaBinducing inase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol. 2001;21:7207-17. doi:10.1128/MCB.21.21.7207-7217.2001. (Pubitemid 32953475)
8. Chatterjee D, et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem. 2004;279:17515-23. doi:10.1074/jbc. M313816200. (Pubitemid 38560515)
9. Lee HC, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 2006;131:1208-17. doi:10.1053/j.gastro.2006.07.012. (Pubitemid 44498689)
10. Al-Mulla F, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol. 2006;24:5672-9. doi:10.1200/JCO.2006.07.5499. (Pubitemid 46631308)
11. Fu Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95:878-89.
12. Schuierer MM, et al. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signalregulated kinase signaling in melanoma cell lines. Cancer Res. 2004;64:5186-92. doi:10.1158/0008-5472.CAN- 03-3861. (Pubitemid 39006537)
13. Surveillance Epidemiology and End Results Program Website. 1973-2003 Public Use Data. Available from: http//seer.cancer.gov/publicdata. Accessed 17 Aug 2006.
14. Wanebo HJ, et al. Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg. 1993;218:583-92. doi:10.1097/00000658- 199321850-00002.
15. MacDonald JS. Gastric cancer-New therapeutic options. N Engl J Med. 2006;355:76-7. doi:10.1056/NEJMe068121. (Pubitemid 43053709)
16. Bonenkamp JJ, et al. Extended lymphnode dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med. 1999;340: 908-14. doi:10.1056/ NEJM199903253401202. (Pubitemid 29141051)
17. Hagan S, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res. 2005;11:7392-7. doi:10.1158/1078-0432.CCR-05-0283. (Pubitemid 41507699)
18. Chatterjee D, et al. Inverse association between Raf Kinase inhibitory protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients implications for clinical outcome. Clin Cancer Res. 2008;14:2994-3001. doi:10.1158/1078-0432.CCR-07-4496.
19. Shevde LA, Welch DR. Metastasis suppressor pathwaysan evolving paradigm. Cancer Lett. 2003;198:1-20. doi:10.1016/S0304-3835(03)00304-5. (Pubitemid 37289098)